MIST ▲ +7.0% - Milestone Pharmaceuticals Inc.
$MIST - Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
09-OCT-2026 08:00 AM ET
Share this post
More filings for $MIST
MIST ▲ +2.3% - Milestone Pharmaceuticals Inc.Sep 24, 2026MIST ▲ +5.9% - Milestone Pharmaceuticals Inc.Sep 3, 2026MIST ▼ -0.9% - Milestone Pharmaceuticals Inc.Sep 2, 2026
View full $MIST filing history →💬 Comments
Loading comments…
Leave a comment